187 related articles for article (PubMed ID: 11160727)
1. Antibody-mediated neutralization of primary human immunodeficiency virus type 1 isolates: investigation of the mechanism of inhibition.
Spenlehauer C; Kirn A; Aubertin AM; Moog C
J Virol; 2001 Mar; 75(5):2235-45. PubMed ID: 11160727
[TBL] [Abstract][Full Text] [Related]
2. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
[TBL] [Abstract][Full Text] [Related]
3. Passage of HIV-1 molecular clones into different cell lines confers differential sensitivity to neutralization.
Zhang YJ; Fredriksson R; McKeating JA; Fenyö EM
Virology; 1997 Nov; 238(2):254-64. PubMed ID: 9400598
[TBL] [Abstract][Full Text] [Related]
4. Neutralization of primary and T-cell line adapted isolates of human immunodeficiency virus type 1: role of V3-specific antibodies.
Beddows S; Louisirirotchanakul S; Cheingsong-Popov R; Easterbrook PJ; Simmonds P; Weber J
J Gen Virol; 1998 Jan; 79 ( Pt 1)():77-82. PubMed ID: 9460926
[TBL] [Abstract][Full Text] [Related]
5. Inter-subtype cross-neutralizing antibodies recognize epitopes on cell-associated HIV-1 virions.
Donners H; Davis D; Willems B; van der Groen G
J Med Virol; 2003 Feb; 69(2):173-81. PubMed ID: 12683404
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 envelope pseudotyped viral vectors and infectious molecular clones expressing the same envelope glycoprotein have a similar neutralization phenotype, but culture in peripheral blood mononuclear cells is associated with decreased neutralization sensitivity.
Louder MK; Sambor A; Chertova E; Hunte T; Barrett S; Ojong F; Sanders-Buell E; Zolla-Pazner S; McCutchan FE; Roser JD; Gabuzda D; Lifson JD; Mascola JR
Virology; 2005 Sep; 339(2):226-38. PubMed ID: 16005039
[TBL] [Abstract][Full Text] [Related]
7. Chimeric viruses expressing primary envelope glycoproteins of human immunodeficiency virus type I show increased sensitivity to neutralization by human sera.
McKeating JA; Zhang YJ; Arnold C; Frederiksson R; Fenyö EM; Balfe P
Virology; 1996 Jun; 220(2):450-60. PubMed ID: 8661395
[TBL] [Abstract][Full Text] [Related]
8. Postattachment neutralization of a primary strain of HIV type 1 in peripheral blood mononuclear cells is mediated by CD4-specific antibodies but not by a glycoprotein 120-specific antibody that gives potent standard neutralization.
McInerney TL; Dimmock NJ
AIDS Res Hum Retroviruses; 2001 Nov; 17(17):1645-54. PubMed ID: 11779352
[TBL] [Abstract][Full Text] [Related]
9. Interaction between virion-bound host intercellular adhesion molecule-1 and the high-affinity state of lymphocyte function-associated antigen-1 on target cells renders R5 and X4 isolates of human immunodeficiency virus type 1 more refractory to neutralization.
Fortin JF; Cantin R; Bergeron MG; Tremblay MJ
Virology; 2000 Mar; 268(2):493-503. PubMed ID: 10704357
[TBL] [Abstract][Full Text] [Related]
10. Polyclonal immunoglobulin G from patients neutralizes human immunodeficiency virus type 1 primary isolates by binding free virions, but without interfering with an initial CD4-independent attachment of the virus to primary blood mononuclear cells.
Burrer R; Haessig-Einius S; Aubertin AM; Moog C
J Virol; 2003 Nov; 77(21):11385-97. PubMed ID: 14557624
[TBL] [Abstract][Full Text] [Related]
11. Potent broad cross-neutralizing sera inhibit attachment of primary HIV-1 isolates (groups M and O) to peripheral blood mononuclear cells.
Beirnaert E; De Zutter S; Janssens W; van der Groen G
Virology; 2001 Mar; 281(2):305-14. PubMed ID: 11277702
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus type 1 neutralization measured by flow cytometric quantitation of single-round infection of primary human T cells.
Mascola JR; Louder MK; Winter C; Prabhakara R; De Rosa SC; Douek DC; Hill BJ; Gabuzda D; Roederer M
J Virol; 2002 May; 76(10):4810-21. PubMed ID: 11967298
[TBL] [Abstract][Full Text] [Related]
13. Epitopes corresponding to the envelope genetic subtype are present on the surface of free virions of HIV-1 group M primary isolates and can be detected in neutralization assays with extended incubation phases.
Davis D; Donners H; Willems B; Vermoesen T; Heyndrickx L; Colebunders R; van der Groen G
J Med Virol; 2003 Nov; 71(3):332-42. PubMed ID: 12966537
[TBL] [Abstract][Full Text] [Related]
14. Resistance to infection by HIV-1 of peripheral blood mononuclear cells from HIV-1-infected patients is probably mediated by neutralizing antibodies.
Tremblay M; Numazaki K; Li XG; Gornitsky M; Hiscott J; Wainberg MA
J Immunol; 1990 Nov; 145(9):2896-901. PubMed ID: 1698866
[TBL] [Abstract][Full Text] [Related]
15. Dichotomy in cross-clade reactivity and neutralization by HIV-1 sera: Implications for active and passive immunotherapy.
Cavacini LA; Duval M; Patil A; Wood C; Mayer KH; Ruprecht RM; Posner MR
J Med Virol; 2005 Jun; 76(2):146-52. PubMed ID: 15834877
[TBL] [Abstract][Full Text] [Related]
16. Preliminary in vitro growth cycle and transmission studies of HIV-1 in an autologous primary cell assay of blood-derived macrophages and peripheral blood mononuclear cells.
Tsai WP; Conley SR; Kung HF; Garrity RR; Nara PL
Virology; 1996 Dec; 226(2):205-16. PubMed ID: 8955040
[TBL] [Abstract][Full Text] [Related]
17. T cell line passage can select for pre-existing neutralization-sensitive variants from the quasispecies of primary human immunodeficiency virus type-1 isolates.
Quakkelaar ED; Beaumont T; van Nuenen AC; van Alphen FP; Boeser-Nunnink BD; van 't Wout AB; Schuitemaker H
Virology; 2007 Mar; 359(1):92-104. PubMed ID: 17052738
[TBL] [Abstract][Full Text] [Related]
18. Infection of human peripheral blood mononuclear cells by erythrocyte-bound HIV-1: effects of antibodies and complement.
Beck Z; Brown BK; Matyas GR; Polonis VR; Rao M; Alving CR
Virology; 2011 Apr; 412(2):441-7. PubMed ID: 21334707
[TBL] [Abstract][Full Text] [Related]
19. HIV sensitivity to neutralization is determined by target and virus producer cell properties.
Mann AM; Rusert P; Berlinger L; Kuster H; Günthard HF; Trkola A
AIDS; 2009 Aug; 23(13):1659-67. PubMed ID: 19581791
[TBL] [Abstract][Full Text] [Related]
20. Mitigation of variation observed in a peripheral blood mononuclear cell (PBMC) based HIV-1 neutralization assay by donor cell pooling.
Wieczorek L; Brown BK; Delsarto Macedo C; Wesberry-Schmierer M; Ngauy V; Rosa Borges A; Michael NL; Marovich MA; Montefiori DC; Polonis VR
Virology; 2013 Dec; 447(1-2):240-8. PubMed ID: 24210120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
